Seegene said on the 27th that it attended the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in Munich, Germany. At the event, Seegene showcased Qureca and Stagora, platforms that automate PCR (polymerase chain reaction) testing and analyze results in real time.
Qureca is a platform that automates the PCR testing process. From sample loading to pre-processing, nucleic acid extraction, amplification, and result analysis, it can be handled unmanned without manual work. The company said it can streamline repetitive testing steps and reduce errors.
Stagora collects and analyzes PCR test results in real time. It is a statistics platform that allows medical staff to understand overseas infectious disease trends. It is also possible to compare patient test results with regional statistics. Baek Young-seok, executive vice president overseeing new businesses at Seegene, said, "By combining automated testing with real-time data analysis, we can understand infectious disease trends."
Eric Frizda, head of Seegene's French subsidiary, said, "Europe demands rapid and accurate infectious disease diagnostics," adding, "A more efficient testing environment is needed." James Yanchi, head of Seegene's Canadian subsidiary, said, "Test volumes are also increasing in the North American market," adding, "An automated testing system will be able to meet this demand."
A representative of a German hospital who attended the meeting said, "It appears it will help provide a more multi-dimensional understanding of the infection situation." A Seegene representative said, "We plan to focus on expanding Stagora's overseas rollout," adding, "We will speed up the final steps toward Qureca's commercialization."